Alleged isotretinoin-associated inflammatory bowel disease: Disproportionate reporting by attorneys to the Food and Drug Administration Adverse Event Reporting System

Attorney-initiated reports inflate the pharmacovigilance signal of isotretinoin-associated IBD in the FAERS.